CD44 and myeloid sarcoma: Our observation that MIF DDT and CD44 are hyper-expressed in the peripheral CD4+ T cells from patients with CIS concurs with the emerging concept of the major pathogenetic role played from MIF and DDT in MS, and progressive MS [8].